View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Sino Biophamaceutical Ltd: 1 director

A director at Sino Biophamaceutical Ltd bought 2,500,000 shares at 2.322HKD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Socovesa Sa: 2 directors

Two Directors at Socovesa Sa sold/bought 450,000 shares at 81.000CLP. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

GigaCloud Technology Inc: 1 director

A director at GigaCloud Technology Inc sold/sold after exercising options 88,000 shares at 32.340USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...

 PRESS RELEASE

Elanders AB: Report from the Annual General Meeting 2024

Elanders AB: Report from the Annual General Meeting 2024 The Annual General Meeting, led by Chairman of the Board Dan Frohm, decided to: adopt the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet, discharge the members of the Board and the Chief Executive Officer from liability for the financial year 2023,according to the proposal in the summons, distribute a dividend of SEK 4.15 per share for 2023. The record date for the dividend is proposed to be 23 April 2024 and it is expected that the dividend will be disbursed by Euroclea...

 PRESS RELEASE

Elanders AB: Rapport från årsstämman 2024

Elanders AB: Rapport från årsstämman 2024 Stämman, som leddes av styrelsens ordförande Dan Frohm, beslöt att: fastställa resultat- och balansräkningen samt koncernresultat- och koncernbalansräkningen,bevilja styrelsens ledamöter och verkställande direktören ansvarsfrihet för verksamhetsåret 2023,enligt styrelsens förslag i kallelsen fastställa att utdelning för 2023 lämnas med 4,15 kronor per aktie samt att avstämningsdagen för utdelning är den 23 april 2024, vilket innebär att utdelningen beräknas utsändas genom Euroclear Sweden AB den 26 april 2024,enligt förslaget i kallelsen för verk...

Hybridan Small Cap Feast - 19 April 24

19th April 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced Dish of the day Admissions: Delistings: What’s baking in the oven? ** Potential**** Initial Public Offerings: Reverse Takeovers: 16 April 2024: Electric Guitar (ELEG.L) Concurrent with its Admission to trading on AIM, Electric Guitar is proposing to acquire the entire issued share capital of 3radi...

 PRESS RELEASE

Royalty Pharma to Announce First Quarter 2024 Financial Results on May...

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the “Investors” page of the company’s website at to obtain conference call information and to view the live webcast. A replay of the conference call a...

 PRESS RELEASE

Tikehau Capital : Déclaration des transactions sur actions propres réa...

PARIS--(BUSINESS WIRE)-- Regulatory News: Conformément à l’article 5 du Règlement européen n° 596/2014 (Règlement MAR – Market Abuse Regulation), les informations détaillées sont disponibles sur le site de Tikehau Capital (Paris:TKO) :   Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres)       Prix pondéré moyen journalier d'acquisition Code identifiant marché TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 12/04/20...

 PRESS RELEASE

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Y...

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 The Company Concluded the Year With Revenue Doubling, Alongside Substantial Improvements in Gross Profit Margins and Net Income FORT LAUDERDALE, FL, April 19, 2024 (GLOBE NEWSWIRE) -- via – VPR Brands LP (OTCQB: VPRB), a leader in the innovation and monetization of intellectual properties within the electronic cigarette and vaporizer sector, today announced its financial results for the fiscal year ended December 31, 2023. Demonstrating significant growth and enhanced operational efficiency, the company concl...

 PRESS RELEASE

Form 8.3 - Tritax Big Box Reit Plc

Form 8.3 - Tritax Big Box Reit Plc 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this form ...

E-Data Teknoloji Pazarlam: 1 director

A director at E-Data Teknoloji Pazarlam sold 556,682 shares at 22.380TRY and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

 PRESS RELEASE

Form 8.3 - Hipgnosis Songs Fund Limited

Form 8.3 - Hipgnosis Songs Fund Limited 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this ...

Moody's Ratings affirms Centrica's ratings; stable outlook

Moody's Ratings (Moody's) has today affirmed the Baa2 long-term issuer and senior unsecured ratings, and the Ba1 junior subordinated debt rating of Centrica plc (Centrica). Concurrently, Moody's has also affirmed Centrica's Prime-2 short-term Commercial Paper rating. The outlook remains stable. A ...

 PRESS RELEASE

Form 8.3 - Mattioli Woods

Form 8.3 - Mattioli Woods 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this form relates: ...

 PRESS RELEASE

HOL-Holding(s) in Company

easyJet plc (EZJ) HOL-Holding(s) in Company 19-Apr-2024 / 13:00 GMT/BST TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B7KR2P84 Issuer Name EASYJET PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Bank of America Corporation City of registered office (if applicable)   Country of registered office (if applicable) US 4. ...

 PRESS RELEASE

Alliance Trust PLC - Net Asset Value

Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC                 At the close of business Thursday 18 April 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 1243.9p                 -       including income, 1248.5p   The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income, 1248.4p -       including income, 1253.0p For further information, please contact: -  Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated in...

 PRESS RELEASE

Lakeland Bancorp Announces First Quarter Results

Lakeland Bancorp Announces First Quarter Results OAK RIDGE, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Lakeland Bancorp, Inc. (NASDAQ: LBAI) (the “Company”), the parent company of Lakeland Bank (“Lakeland”), reported net income of $19.8 million and earnings per diluted share ("EPS") of $0.30 for the three months ended March 31, 2024 compared to net income of $19.8 million and diluted EPS of $0.30 for the three months ended March 31, 2023. For the first quarter of 2024, annualized return on average assets was 0.73%, annualized return on average common equity was 6.79% and annualized return o...

BCnC Co Ltd: 1 director

A director at BCnC Co Ltd sold 640,000 shares at 19,332.000KRW and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Netsol Technologies Limited: 1 director

A director at Netsol Technologies Limited sold 50,000 shares at 120.720PKR and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

 PRESS RELEASE

Preliminary Results for the Year Ended 31 December 2023

Preliminary Results for the Year Ended 31 December 2023 19 April 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2023 Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain, announces its audited preliminary results for the year ended 31 December 2023. For more information, please contact: Biodexa Pharmaceuticals PLCStephen Stamp, CEO, CFOTel: +44 (0)29 2...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch